Revival Healthcare Capital Closes $500 Million Fund For Strategic Growth Investments

Private equity firm Revival Healthcare Capital (“Revival”) today announced the closing of RVLHC II with total capital commitments of $500 million. The fund will pursue strategic growth opportunities in which Revival will invest into a high potential target company where a corporate strategic partner will have a structural option or right to acquire the company in the future. This strategy leverages Revival’s capacity as operators and investors to build collaborative partnerships that increase corporate partners’ probability of return on future growth investments and provide accelerated paths for target companies to advance innovative medical device technologies into global markets.